IL161429A0 - Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same - Google Patents
Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL161429A0 IL161429A0 IL16142902A IL16142902A IL161429A0 IL 161429 A0 IL161429 A0 IL 161429A0 IL 16142902 A IL16142902 A IL 16142902A IL 16142902 A IL16142902 A IL 16142902A IL 161429 A0 IL161429 A0 IL 161429A0
- Authority
- IL
- Israel
- Prior art keywords
- benzoxazine
- same
- pharmaceutical compositions
- compositions containing
- benzothiazine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN848CH2001 | 2001-10-16 | ||
| PCT/IB2002/004275 WO2003033481A1 (fr) | 2001-10-16 | 2002-10-15 | Derives de benzoxazine et de benzothiazine, et compositions pharmaceutiques contenant ces derives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161429A0 true IL161429A0 (en) | 2004-09-27 |
Family
ID=11097010
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16143102A IL161431A0 (en) | 2001-10-16 | 2002-10-15 | beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| IL16142902A IL161429A0 (en) | 2001-10-16 | 2002-10-15 | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16143102A IL161431A0 (en) | 2001-10-16 | 2002-10-15 | beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20110105748A1 (fr) |
| EP (2) | EP1436247A1 (fr) |
| JP (2) | JP2005505617A (fr) |
| CN (2) | CN1589258A (fr) |
| BR (2) | BR0213350A (fr) |
| CA (2) | CA2463685A1 (fr) |
| HR (2) | HRP20040350A2 (fr) |
| HU (2) | HUP0401649A3 (fr) |
| IL (2) | IL161431A0 (fr) |
| NO (2) | NO20041998L (fr) |
| NZ (1) | NZ532285A (fr) |
| PL (2) | PL369655A1 (fr) |
| WO (2) | WO2003033456A1 (fr) |
| ZA (2) | ZA200402858B (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070093476A1 (en) * | 2003-10-28 | 2007-04-26 | Bhunia Debnath | Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| EP2305352A1 (fr) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | Inhibiteurs de la 5-alpha-reductase pour le traitement d'hommes aux troubles métaboliques et anthropométriques |
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| US7749995B2 (en) * | 2006-05-11 | 2010-07-06 | Janssen Pharmaceutica Nv | 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors |
| WO2008079427A1 (fr) | 2006-05-11 | 2008-07-03 | Janssen Pharmaceutica N.V. | Dérivés de 1,2,3,4-tétrahydro-quinoline en tant qu'inhibiteurs de la cetp |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| EP3788877A1 (fr) * | 2007-04-11 | 2021-03-10 | Omeros Corporation | Compositions et procédés pour la prophylaxie et le traitement de la toxicomanie |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA2930674A1 (fr) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles |
| JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
| AU2009309037A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| HUE050267T2 (hu) | 2009-02-16 | 2020-11-30 | Nogra Pharma Ltd | Alkilamido vegyületek és alkalmazásuk |
| AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| CA2798911C (fr) | 2010-05-19 | 2018-07-03 | Unilever Plc | Theobromine pour l'elevation de hdl-cholesterol |
| WO2012027331A1 (fr) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| ES2652662T3 (es) | 2011-02-25 | 2018-02-05 | Merck Sharp & Dohme Corp. | Novedosos derivados de azabencimidazol cíclicos útiles como agentes antidiabéticos |
| WO2013082106A1 (fr) | 2011-12-02 | 2013-06-06 | The General Hospital Corporation | Différenciation en adipocytes bruns |
| EA030762B1 (ru) | 2012-02-09 | 2018-09-28 | Ногра Фарма Лимитед | Способы лечения фиброза |
| EA201491894A1 (ru) | 2012-04-18 | 2015-02-27 | Ногра Фарма Лимитед | Способы лечения непереносимости лактозы |
| AU2013296470B2 (en) | 2012-08-02 | 2016-03-17 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| MX2015010935A (es) | 2013-02-22 | 2015-10-29 | Merck Sharp & Dohme | Compuestos biciclicos antidiabeticos. |
| WO2014139388A1 (fr) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| CA2905438A1 (fr) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonistes de la guanylate cyclase et leurs utilisations |
| CN105164220B (zh) * | 2013-04-30 | 2017-11-03 | 3M创新有限公司 | 用于制备聚(苯并噁嗪)的方法 |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| WO2015051496A1 (fr) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Composés tricycliques antidiabétiques |
| EP3166923B1 (fr) | 2014-07-10 | 2023-03-15 | SpecGx LLC | Procédé pour préparer des phénylalcanes substitués |
| WO2018106518A1 (fr) | 2016-12-06 | 2018-06-14 | Merck Sharp & Dohme Corp. | Composés hétérocycliques antidiabétiques |
| US10968232B2 (en) | 2016-12-20 | 2021-04-06 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
| WO2020161362A1 (fr) | 2019-02-08 | 2020-08-13 | Nogra Pharma Limited | Procédé de fabrication d'acide 3-(4'-aminophényl)-2-méthoxypropionique, et analogues et intermédiaires de celui-ci |
| CN113968781A (zh) * | 2021-11-11 | 2022-01-25 | 上海吉奉生物科技有限公司 | 一种(s)-2-羟基-3-邻甲基丙酸的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996028405A1 (fr) * | 1995-03-10 | 1996-09-19 | Nitto Chemical Industry Co., Ltd. | Procede de production de derives de 1,2-ethanediol |
| NZ504106A (en) | 1998-05-27 | 2003-02-28 | Dr | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them |
| SK15092001A3 (sk) * | 1999-04-28 | 2002-05-09 | Dr. Reddy's Research Foundation | Substituované bicyklické heterocyklické zlúčeniny, spôsob ich prípravy a ich použitie ako antiobezitných a hypocholesterolemických činidiel |
| SE9904421D0 (sv) * | 1999-12-03 | 1999-12-03 | Astra Ab | New compounds |
| WO2002030914A1 (fr) | 2000-10-12 | 2002-04-18 | Dr. Reddy's Research Foundation | Sels de derives de benzothiazine et de benzoxazine et compositions pharmaceutiques a base de ces sels |
-
2002
- 2002-10-15 CA CA002463685A patent/CA2463685A1/fr not_active Abandoned
- 2002-10-15 HU HU0401649A patent/HUP0401649A3/hu unknown
- 2002-10-15 PL PL02369655A patent/PL369655A1/xx not_active Application Discontinuation
- 2002-10-15 WO PCT/IB2002/004274 patent/WO2003033456A1/fr active IP Right Grant
- 2002-10-15 CN CNA028227239A patent/CN1589258A/zh active Pending
- 2002-10-15 US US10/492,452 patent/US20110105748A1/en not_active Abandoned
- 2002-10-15 IL IL16143102A patent/IL161431A0/xx unknown
- 2002-10-15 CA CA002463686A patent/CA2463686A1/fr not_active Abandoned
- 2002-10-15 US US10/492,454 patent/US7365064B2/en not_active Expired - Fee Related
- 2002-10-15 WO PCT/IB2002/004275 patent/WO2003033481A1/fr active Application Filing
- 2002-10-15 IL IL16142902A patent/IL161429A0/xx unknown
- 2002-10-15 NZ NZ532285A patent/NZ532285A/en unknown
- 2002-10-15 CN CNA028238222A patent/CN1596249A/zh active Pending
- 2002-10-15 HU HU0401647A patent/HUP0401647A3/hu unknown
- 2002-10-15 JP JP2003536197A patent/JP2005505617A/ja active Pending
- 2002-10-15 EP EP02801466A patent/EP1436247A1/fr not_active Withdrawn
- 2002-10-15 BR BR0213350-4A patent/BR0213350A/pt not_active IP Right Cessation
- 2002-10-15 JP JP2003536221A patent/JP2005527480A/ja not_active Withdrawn
- 2002-10-15 BR BR0213380-6A patent/BR0213380A/pt not_active Application Discontinuation
- 2002-10-15 EP EP02775090A patent/EP1436268A1/fr not_active Withdrawn
- 2002-10-15 PL PL02369732A patent/PL369732A1/xx not_active Application Discontinuation
-
2004
- 2004-04-15 ZA ZA200402858A patent/ZA200402858B/xx unknown
- 2004-04-16 HR HR20040350A patent/HRP20040350A2/xx not_active Application Discontinuation
- 2004-04-16 HR HR20040349A patent/HRP20040349A2/hr not_active Application Discontinuation
- 2004-04-16 ZA ZA200402910A patent/ZA200402910B/en unknown
- 2004-05-14 NO NO20041998A patent/NO20041998L/no not_active Application Discontinuation
- 2004-05-14 NO NO20041994A patent/NO20041994L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2463685A1 (fr) | 2003-04-24 |
| US20050113368A1 (en) | 2005-05-26 |
| IL161431A0 (en) | 2004-09-27 |
| CN1589258A (zh) | 2005-03-02 |
| HRP20040349A2 (en) | 2005-06-30 |
| NZ532285A (en) | 2005-11-25 |
| EP1436268A1 (fr) | 2004-07-14 |
| CA2463686A1 (fr) | 2003-04-24 |
| JP2005505617A (ja) | 2005-02-24 |
| HUP0401649A3 (en) | 2007-05-29 |
| NO20041998L (no) | 2004-07-02 |
| WO2003033481A1 (fr) | 2003-04-24 |
| US7365064B2 (en) | 2008-04-29 |
| EP1436247A1 (fr) | 2004-07-14 |
| HUP0401647A3 (en) | 2008-05-28 |
| WO2003033456A1 (fr) | 2003-04-24 |
| CN1596249A (zh) | 2005-03-16 |
| HRP20040350A2 (en) | 2005-06-30 |
| ZA200402858B (en) | 2005-01-12 |
| PL369732A1 (en) | 2005-05-02 |
| NO20041998D0 (no) | 2004-05-14 |
| HUP0401647A2 (hu) | 2004-11-29 |
| NO20041994L (no) | 2004-05-14 |
| PL369655A1 (en) | 2005-05-02 |
| BR0213350A (pt) | 2004-10-13 |
| ZA200402910B (en) | 2005-01-13 |
| BR0213380A (pt) | 2005-02-01 |
| HUP0401649A2 (hu) | 2004-11-29 |
| US20110105748A1 (en) | 2011-05-05 |
| JP2005527480A (ja) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161429A0 (en) | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same | |
| IL158523A0 (en) | Epothilone derivatives and pharmaceutical compositions containing the same | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL158076A0 (en) | Benzamidine derivatives and pharmaceutical compositions containing the same | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL157029A0 (en) | Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same | |
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| IL241211A0 (en) | History of maytansinoid and pharmaceutical preparations containing them | |
| IL159765A0 (en) | Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL159086A0 (en) | 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same | |
| IL158041A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| IL166482A0 (en) | Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same | |
| AU2002306269A1 (en) | N-arylphenylacetamide derivatives and pharmaceutical composition containing the same | |
| IL176005A0 (en) | 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same | |
| IL173602A0 (en) | Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same | |
| IL173627A0 (en) | 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same | |
| IL173051A0 (en) | N-glucoside derivatives and pharmaceutical compositions containing the same | |
| IL171997A0 (en) | Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL175214A0 (en) | 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same | |
| IL151829A0 (en) | Carbamate derivatives and pharmaceutical compositions containing the same |